[Lys3]-Bombesin – 5 mg

Overview

Discover the potential of [Lys3]-Bombesin, a peptide that plays a crucial role in PET (Positron Emission Tomography) imaging for the detection of gastrin-releasing peptide receptor (GRPR) positive prostate cancer. This 5 mg peptide not only helps visualize tumors but also serves as a promising tool for targeted cancer therapies. When combined with specific monoclonal antibodies, [Lys3]-Bombesin can trigger CD64-dependent monocyte and neutrophil-mediated lysis of small cell carcinoma, making it an invaluable asset in oncology research.

Key Features

• Facilitates PET imaging for prostate cancer detection
• Targets GRPR receptors for enhanced specificity
• Enables immunoconjugate formulation for targeted therapies
• Promotes efficient lysis of small cell carcinoma cells
• Available in a convenient 5 mg quantity

Specifications

Property	Details
Product Name	[Lys3]-Bombesin
Size	5 mg
Category	Peptides

FAQ

What is [Lys3]-Bombesin used for?

[Lys3]-Bombesin is primarily used for PET imaging to detect prostate cancer that expresses gastrin-releasing peptide receptors (GRPR).

Can [Lys3]-Bombesin be used for therapeutic purposes?

Yes, it can be conjugated with monoclonal antibodies to create immunoconjugates that specifically target and induce lysis in cancer cells.

Where can I find more peptides like [Lys3]-Bombesin?

You can explore our extensive collection of peptides designed for various applications in research and diagnostics.

Don’t miss out on the opportunity to enhance your research with [Lys3]-Bombesin. Order now to secure this essential peptide for your laboratory and take a step closer to advancing cancer diagnostics and therapy!

Related Products

• PKG Substrate [RKRSRAE], Glasstide
• Autocamtide-2 [KKALRRQETVDAL]
• CREBtide [KRREILSRRPSYR], 5-FAM labeled